£116k
No changevs Jun 2024Active12064132Private limited companyLondon
CHESTERFIELD PHARMA LTD
Significant control: Khalid Mohamed Tantawi Zagaloul (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Chesterfield Pharma Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Chesterfield Pharma Ltd sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CHESTERFIELD PHARMA LTD is an active private limited company (company number 12064132) incorporated on 21 June 2019, registered in London. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest micro accounts cover the period ending 30 June 2025, showing net assets of £116k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the top quarter of 435 comparable companies in London (median £2,000, upper quartile £90k).
02
Ownership and control
- Mr Khalid Mohamed Tantawi Zagaloul
- owns 75–100% of shares
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 21 June 20197 yrs ago
- Next accounts due
- 30 March 2027in 155 days
- Confirmation statement due
- 5 July 2027in 252 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
1
No changevs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £116k | — | — | £125k | — | — | 1 |
| 30 June 2024 | £116k | — | — | £125k | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £116,113 at 30 June 2025
- Incorporated five or more years agoIncorporated 21 June 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 252 days
- Next accounts duein 155 days
- Accounts period endNet assets £116k · micro accounts
- Accounts period endNet assets £116k · micro accounts
- Incorporated
08
Similar companies in London
- NOVACELL UK LIMITEDLondon · inc. Jul 2019
- SOTERIA HOLDINGS LTDLondon · inc. Jul 2019
- MAXX PHARM LTDLondon · inc. Jul 2019
- SARCORP LIMITEDLondon · inc. May 2019
- GLOBAL INVESTMENT KAZ LIMITEDLondon · inc. May 2019
- GLOBOCEUTICS LTDLondon · inc. Aug 2019
All companies incorporated on 21 June 2019 · in Jun 2019.
09
Reminders for CHESTERFIELD PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.